Invited Speakers: Chairpersons:
Dr. Paul A. Keifer
Varian NMR Instruments
Dr. Ming-Daw Tsai
The Ohio State University
Additional Speakers:
Dr. Michael Andrec
Rutgers University
Dr. Ad Bax
National Institute of Diabetes and Digestive and Kidney Diseases, NIH
Dr. Joel Berendzen
Los Alamos National Laboratory
Dr. Wayne Fairbrother
Genentech, Inc.
Dr. Bennett T. Farmer II
Bristol-Myers Squibb Pharmaceutical Research Institute
Dr. Joel R. Garbow
Monsanto Company
Dr. Joyce Prosser James
Bruker Instruments
Dr. Kelly A. Keating
Pacific Northwest National Laboratory
Dr. Paul A. Keifer
Varian NMR Instruments
Dr. John L. Markley
University of Wisconsin, Madison
Dr. Jonathan M. Moore
Vertex Pharmaceuticals Incorporated
Dr. James D. Myers
Pacific Northwest National Laboratory
Dr. Stanley J. Opella
University of Pennsylvania
Dr. Art Palmer
Columbia University
Dr. Charles Sanders
Case Western Reserve University
Dr. John Shockcor
DuPont Merck and University of London
Dr. Michael F. Summers
University of Maryland, Baltimore County
Dr. Ming-Daw Tsai
The Ohio State University
Dr. Andrew Webb
University of Illinois at Urbana-Champaign
Program:
Session: Improvements in NMR Technologies
New Technical Developments in NMR
Perdeuteration and Selective Protonation in Solution-State Structural Studies
NMR Microprobes for High-Resolution Studies
Accurate Estimation of Global Dynamic Parameters from NMR Relaxation Data
Session: Sharing Resources and Facilities (in a starburst or flag): Plus Live Internet Demonstration)
Developing Tools for Streamlining Operations of a Shared Facility
Remote Research Using the EMSL Virtual NMR Facility
Session: Structural and Dynamic Analyses of Proteins and New Drug Targets
NMR Studies of HIV-1 Genome Recognition
Structure-Function Analysis of the INK4 Family of Tumor Suppressors
Studies of Protein Dynamics Using NMR
Sample Optimization Strategies for Membrane Proteins
NMR Structural Studies of Membrane Proteins
High-Throughput Crystallography and Structural Genomics
NMR Studies of Novel Phage-Derived Peptide Antagonists of Protein:Protein Interactions
Session: NMR for Drug Discovery
New NMR Technologies for Drug Discovery
The SHAPES Strategy: An NMR-Based Approach for Lead Generation in Drug Discovery
Development and Applications of HPLC, NMR, and HPLC-NMR/MS to Drug Discovery
The Identification of Bulk Drug Impurities Using LC-NMR Spectroscopy
Registration :
Advance Registration (by September 18, 1998): commercial-$845, academic-$395
On-Site Registration: commercial: $945 academic-$445
Students and Fellows: contact producer
Deadline for Abstracts: September 18, 1998
Email for Requests and Registration: csussman@healthtech.com